Skip to main content

1 Result(s)

within Peggy Chu Remove this filter

and

  1. No Access

    Article

    Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in a Chinese population: a prospective multi-centre cohort study

    Androgen deprivation therapy (ADT) use in prostate cancer (PCa) has seen a rising trend. We are looking into the relationship between ADT and development of metabolic diseases in Chinese patients.

    Chris Wong, Peggy Chu, Jeremy Teoh, Peter Chiu… in International Urology and Nephrology (2022)